E-LIB Suche - Ergebnisse für: Laura Pizzuti

1

HER2 mutation as an emerging target in advanced breast canc..:

Bon, Giulia ; Di Lisa, Francesca Sofia ; Filomeno, Lorena...
Cancer Science. , 2024

Link: https://doi.org/10.1111/..

2

Pathologic response and survival after neoadjuvant chemothe..:

Fabbri, Agnese ; Nelli, Fabrizio ; Botticelli, Andrea...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Prognostic value of [18F]-FDG PET/CT in patients with meta-..:

Annovazzi, Alessio ; Rea, Sandra ; Maccora, Daria...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

DARPP-32 and t-DARPP in the development of resistance to an..:

Bon, Giulia ; Krasniqi, Eriseld ; Porru, Manuela...
Neoplasia. 45 (2023) - p. 100937 , 2023

Link: https://doi.org/10.1016/..

5

Adjuvant capecitabine in triple negative breast cancer pati..:

Di Lisa, Francesca Sofia ; Krasniqi, Eriseld ; Pizzuti, Laura...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Sexual dysfunctions in breast cancer patients: evidence in ..:

Vizza, Riccardo ; Capomolla, Elisabetta Maria ; Tosetto, Livia...
Sexual Medicine Reviews. 11 (2023) 3 - p. 179-195 , 2023

Link: https://doi.org/10.1093/..

7

The Role of the CDK4/6 Inhibitor Ribociclib in Locally Adva..:

Botticelli, Andrea ; Fabbri, Agnese ; Roberto, Michela...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

8

Type I IFNs promote cancer cell stemness by triggering the ..:

Musella, Martina ; Guarracino, Andrea ; Manduca, Nicoletta...
Nature Immunology. 23 (2022) 9 - p. 1379-1392 , 2022

Link: https://doi.org/10.1038/..

9

Rising incidence of late stage breast cancer after COVID-19..:

Mentrasti, Giulia ; Cantini, Luca ; Vici, Patrizia...
The Breast. 65 (2022) - p. 164-171 , 2022

Link: https://doi.org/10.1016/..

10

The Impact of the Hippo Pathway and Cell Metabolism on Path..:

Krasniqi, Eriseld ; Di Lisa, Francesca Sofia ; Di Benedetto, Anna...
Cancers. 14 (2022) 19 - p. 4835 , 2022

Link: https://doi.org/10.3390/..

11

Biomarkers of Response and Resistance to CDK4/6 Inhibitors ..:

Krasniqi, Eriseld ; Goeman, Frauke ; Pulito, Claudio...
International Journal of Molecular Sciences. 23 (2022) 23 - p. 14534 , 2022

Link: https://doi.org/10.3390/..

12

COVID‐19 risk in breast cancer patients receiving CDK4/6 in..:

Barba, Maddalena ; Krasniqi, Eriseld ; Pizzuti, Laura...
The Breast Journal. 27 (2021) 4 - p. 359-362 , 2021

Link: https://doi.org/10.1111/..

13

PANHER study: a 20-year treatment outcome analysis from a m..:

Pizzuti, Laura ; Krasniqi, Eriseld ; Sperduti, Isabella...
Therapeutic Advances in Medical Oncology. 13 (2021) - p. 175883592110598 , 2021

Link: https://doi.org/10.1177/..

14

Second-line Eribulin in Triple Negative Metastatic Breast C..:

Krasniqi, Eriseld ; Pizzuti, Laura ; Valerio, Maria Rosaria...
International Journal of Medical Sciences. 18 (2021) 10 - p. 2245-2250 , 2021

Link: https://doi.org/10.7150/..

15

Role of Chemotherapy in Vulvar Cancers: Time to Rethink Sta..:

Mazzotta, Marco ; Pizzuti, Laura ; Krasniqi, Eriseld...
Cancers. 13 (2021) 16 - p. 4061 , 2021

Link: https://doi.org/10.3390/..